Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7891)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kajihara M, Takakura K, Kanai T, Ito Z, Matsumoto Y, Shimodaira S, Okamoto M, Ohkusa T, Koido S. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer. World J Gastroenterol 2016; 22(18): 4446-4458 [PMID: 27182156 DOI: 10.3748/wjg.v22.i18.4446] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i18/4446.htm |
| Number | Citing Articles |
| 1 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
| 2 |
Zhe Sun, Hui Zhao, Li Ma, Yanli Shi, Mei Ji, Xiaodong Sun, Dan Ma, Wei Zhou, Tao Huang, Dongsheng Zhang. The quest for nanoparticle-powered vaccines in cancer immunotherapy. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02311-z
|
| 3 |
Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama, Shigeo Koido. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Cancer Investigation 2019; 37(9): 463 doi: 10.1080/07357907.2019.1661427
|
| 4 |
Efstathios T. Pavlidis, Theodoros E. Pavlidis. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review. Journal of Investigative Surgery 2018; 31(1): 54 doi: 10.1080/08941939.2016.1269854
|
| 5 |
Shuichi Hanada, Tomoko Tsuruta, Kouichi Haraguchi, Masato Okamoto, Haruo Sugiyama, Shigeo Koido. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines. Human Vaccines & Immunotherapeutics 2019; 15(2): 397 doi: 10.1080/21645515.2018.1524238
|
| 6 |
Benjamin A. Weinberg, Michael J. Pishvaian. Current and Emerging Therapies in Pancreatic Cancer. 2018; : 281 doi: 10.1007/978-3-319-58256-6_16
|
| 7 |
Aishwarya Joshi, Nikunj Tandel, Priyanka Tyagi, Sarat K Dalai, Prakash S Bisen, Rajeev K Tyagi. RNA-loaded dendritic cells: more than a tour de force in cancer therapeutics. Immunotherapy 2019; 11(13): 1129 doi: 10.2217/imt-2019-0058
|
| 8 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 9 |
Kasturi Banerjee, Shailendra K. Gautam, Prakash Kshirsagar, Kathleen A. Ross, Gaelle Spagnol, Paul Sorgen, Michael J. Wannemuehler, Balaji Narasimhan, Joyce C. Solheim, Sushil Kumar, Surinder K. Batra, Maneesh Jain. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer 2019; 10(3-4): 52 doi: 10.18632/genesandcancer.189
|
| 10 |
Yasmin Kamal, Stephanie L Schmit, Hildreth Robert Frost, Christopher I Amos. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. Immunotherapy 2020; 12(14): 1083 doi: 10.2217/imt-2020-0026
|